Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 1431 Records) |
| Query Trace: Immunotherapy[original query] |
|---|
| Identification and verification of an ALYREF-involved 5-methylcytosine based signature for stratification of prostate cancer patients and prediction of clinical outcome and response to therapies. Discover. Oncology 2023 5 14 (1): 62. Xiao Tan, Zhouda Cai, Guo Chen, Chao Cai, Jiahong Chen, Yingke Liang, Yangjia Zhuo, Jianming Liu, Liangliang Huang, Bin Ouyang, Yanni Wei, Zhenyu Jia, Junhong Deng, Weide Zhong, Jianming |
| Classification related to immunogenic cell death predicts prognosis, immune microenvironment characteristics, and response to immunotherapy in lower-grade gliomas. Frontiers in immunology 2023 5 14 1102094. Yirui Kuang, Bincan Jiang, Hecheng Zhu, Yi Zhou, Haoxuan Huang, Can Li, Wenlong Zhang, Xuewen Li, Yudong C |
| A risk signature of necroptosis-related lncRNA to predict prognosis and probe molecular characteristics for male with bladder cancer. Medicine 2023 5 102 (18): e33664. Yuzhou Jin, Jiacheng Li, Chenhao Tang, Kangwei He, Donggang Shan, Shenze Yan, Gang De |
| Molecular Profiling Provides Clinical Insights into Targeted and Immunotherapies as well as Colorectal Cancer Prognosis. Gastroenterology 2023 5 . Linwei Guo, Yunjin Wang, Wenxiao Yang, Chenchen Wang, Tian'an Guo, Jingcheng Yang, Zhiming Shao, Guoxiang Cai, Sanjun Cai, Liying Zhang, Xin Hu, Ye |
| Clinical Implication of DNA Damage Response Genes in Advanced Gastric Cancer Stage IV and Recurrent Gastric Cancer Patients After Gastrectomy Treated Palliative Chemotherapy. Journal of Cancer 2023 5 14 (7): 1216-1222. Jeong Eun Kim, Song Ee Park, Hee Jun Kim, In Gyu Hwa |
| Comprehensive Analysis Identifies the PPAR-Targeted Genes Associated with Ovarian Cancer Prognosis and Tumor Microenvironment. PPAR research 2023 5 2023 6637414. Xiao-Fei Leng, Gao-Fa Wang, Hao Yin, Feng Wei, Kang-Kang Zeng, Yi-Qun Zha |
| Mitochondrial metabolic reprogramming-mediated immunogenic cell death reveals immune and prognostic features of clear cell renal cell carcinoma. Frontiers in oncology 2023 5 13 1146657. Lin Yang, Jing Xiong, Sheng Li, Xiaoqiang Liu, Wen Deng, Weipeng Liu, Bin |
| Efficacy and safety analysis of anlotinib combined with PD-1 inhibitors in advanced non-small cell lung cancer: a retrospective cohort study. Journal of thoracic disease 2023 5 15 (4): 2003-2011. Xuanting Ye, Aimi Huang, Yan Zhou, Yanbin Kuang, Weimin Wang, Aiqin Gu, Ling |
| The characteristics and clinical relevance of tumor fusion burden in non-EBV (+) gastric cancer with MSS. BMC gastroenterology 2023 5 23 (1): 153. Yongjun Zhu, Weixin Wu, Liangliang Qiao, Jingfen Ji, Lunxi Duan, Longlong Gong, Dandan Ren, Feifei Li, Lihui Wei, Ke P |
| Circulating tumour DNA kinetics in recurrent/metastatic head and neck squamous cell cancer patients. European journal of cancer (Oxford, England : 1990) 2023 5 188 29-38. Kirsty Taylor, Jinfeng Zou, Marcos Magalhaes, Marc Oliva, Anna Spreafico, Aaron R Hansen, Simon S McDade, Vicky M Coyle, Mark Lawler, Elena Elimova, Scott V Bratman, Lillian L S |
| Genome instability-related LINC02577, LINC01133 and AC107464.2 are lncRNA prognostic markers correlated with immune microenvironment in pancreatic adenocarcinoma. BMC cancer 2023 5 23 (1): 430. Yinjiang Zhang, Yao Wang, Xu He, Rongfei Yao, Lu Fan, Linyi Zhao, Binan Lu, Zongran Pa |
| Development and validation of metabolic models for predicting survival and immune status of hepatocellular carcinoma patients. Advances in clinical and experimental medicine : official organ Wroclaw Medical University 2023 5 . Xueying Li, Mengli Gu, Qiying Hu, Yihui Weng, Xianlei C |
| The expression profile of Gasdermin C-related genes predicts the prognosis and immunotherapy response of pancreatic adenocarcinoma. American journal of cancer research 2023 5 13 (4): 1240-1258. Xiang-Hou Xia, Wen-Juan Yin, Jie-Fei Mao, Peng Liu, Chen-Dong Qin, Jie-Jie Hu, Si-Yuan Liu, Can-Ming Wang, De-Hong Zou, Hong-Jian Yang, Yang Yu, Jian Hua |
| Pathological characteristics and tumour immune microenvironment of lung malignancies with RET rearrangement. Cancer treatment and research communications 2023 4 35 100707. Qing-Yun Gao, Fa-Man Xiao, Xiao-Cheng Lin, Yu-Qing Chen, Yu-Fa Li, Chang Lu, Jun-Wei Su, Quan-Quan Tan, Chan-Yuan Zhang, Jiao Yang, Yi-Long Wu, Hua-Jun Chen, Jin-Ji Ya |
| Are International Units of Anti-HBs Antibodies Always Indicative of Hepatitis B Virus Neutralizing Activity? Vaccines 2023 4 11 (4): . Yada Aronthippaitoon, Nathan Szerman, Nicole Ngo-Giang-Huong, Syria Laperche, Marie-Noelle Ungeheuer, Camille Sureau, Woottichai Khamduang, Catherine Gaudy-Graff |
| Exome-Based Genomic Markers Could Improve Prediction of Checkpoint Inhibitor Efficacy Independently of Tumor Type. International journal of molecular sciences 2023 4 24 (8): . Lorraine Dalens, Julie Lecuelle, Laure Favier, Cléa Fraisse, Aurélie Lagrange, Courèche Kaderbhai, Romain Boidot, Sandy Chevrier, Hugo Mananet, Valentin Derangère, Caroline Truntzer, François Ghiringhel |
| The prognostic value and immunological role of CD44 in pan-cancer study. Scientific reports 2023 4 13 (1): 7011. Shaoyong Chen, Siqin Zhang, Shaohua Chen, Fei |
| A pathway-based mutation signature to predict the clinical outcomes and response to CTLA-4 inhibitors in melanoma. Computational and structural biotechnology journal 2023 4 21 2536-2546. Qian Wang, Xiangmei Li, Jiayue Qiu, Yalan He, Jiashuo Wu, Ji Li, Wei Liu, Junwei H |
| Identification of INSRR as an immune-related gene in the tumor microenvironment of glioblastoma by integrated bioinformatics analysis. Medical oncology (Northwood, London, England) 2023 4 40 (6): 161. Haofuzi Zhang, Mingdong Bao, Dan Liao, Zhuoyuan Zhang, Zhicheng Tian, Erwan Yang, Peng Luo, Xiaofan Jia |
| Clinicopathologic, genomic, and immunophenotypic landscape of ATM mutations in non-small cell lung cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2023 4 . Biagio Ricciuti, Arielle Elkrief, Joao Alessi, Xinan Wang, Yvonne Li, Hersh Gupta, Daniel M Muldoon, Arrien A Bertram, Federica Pecci, Giuseppe Lamberti, Alessandro Di Federico, Adriana Barrichello, Victor R Vaz, Malini Gandhi, Elinton Lee, Geoffrey I Shapiro, Hyesun Park, Mizuki Nishino, James Lindsay, Kristen D Felt, Bijaya Sharma, Andrew D Cherniack, Scott Rodig, Daniel R Gomez, Narek Shaverdian, Mehrdad Rakaee, Chaitanya Bandlamudi, Marc Ladanyi, Pasi A Janne, Adam J Schoenfeld, Lynette M Sholl, Mark M Awad, Michael L Che |
| The combined signatures of the tumour microenvironment and nucleotide metabolism-related genes provide a prognostic and therapeutic biomarker for gastric cancer. Scientific reports 2023 4 13 (1): 6622. Jifeng Liu, Lei Zhong, Dawei Deng, Yunshu Zhang, Qihang Yuan, Dong Sha |
| Mutant-allele dispersion correlates with prognosis risk in patients with advanced non-small cell lung cancer. Journal of cancer research and clinical oncology 2023 4 . Chen-Xu Wang, Jie Yan, Shan Lin, Yi Ding, Yan-Ru Q |
| Mutations Status of NOTCH Signaling Pathway Predict Prognosis of Immune Checkpoint Inhibitors in Colorectal Cancer. Journal of inflammation research 2023 4 16 1693-1709. Anqi Lin, Jiarong Yao, Quan Cheng, Zaoqu Liu, Peng Luo, Jian Zha |
| A senescence-based prognostic gene signature for colorectal cancer and identification of the role of SPP1-positive macrophages in tumor senescence. Frontiers in immunology 2023 4 14 1175490. Sifei Yu, Mengdi Chen, Lili Xu, Enqiang Mao, Silei S |
| Subtype classification based on t cell proliferation-related regulator genes and risk model for predicting outcomes of lung adenocarcinoma. Frontiers in immunology 2023 4 14 1148483. Qin Yang, Weiyuan Zhu, Han Go |
| Comparing Genomic Landscapes of Oral and Cutaneous Squamous Cell Carcinoma of the Head and Neck: Quest for Novel Diagnostic Markers. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2023 4 100190. Ruta Gupta, Dario Strbenac, Laveniya Satgunaseelan, Veronica Ka-Yan Cheung, Harini Narayanappa, Bruce Ashford, Jenny Mitchell, Amarinder Thind, Carsten E Palme, Sydney Ch'ng, Tsu-Hui Hubert Low, James Wykes, Cali E Willet, Tracy Chew, Jean Yang, Marie Ranson, Jonathan R Cla |
| Basement membrane-related regulators for prediction of prognoses and responses to diverse therapies in hepatocellular carcinoma. BMC medical genomics 2023 4 16 (1): 81. Ruili Ding, Chuanbing Zhao, Yixin Jing, Rong Chen, Qingtao Me |
| Overall survival in patients with advanced non-small cell lung cancer with KRAS G12C mutation with or without STK11 and/or KEAP1 mutations in a real-world setting. BMC cancer 2023 4 23 (1): 352. Julian Cristina, Pal Navdeep, Gershon Anda, Evangelista Marie, Purkey Hans, Lambert Peter, Shi Zhen, Zhang Qi |
| Integration analysis based on fatty acid metabolism robustly predicts prognosis, dissecting immunity microenvironment and aiding immunotherapy for soft tissue sarcoma. Frontiers in genetics 2023 4 14 1161791. Liu Binfeng, He Shasha, Li Chenbei, Feng Chengyao, Wang Hua, Zhang Haixia, Tu Chao, Li Zhiho |
| Identification of novel immune-related molecular subtypes and a prognosis model to predict thyroid cancer prognosis and drug resistance. Frontiers in pharmacology 2023 4 14 1130399. Zhang Wei, Liu Ting, Li Xinyi, Li Tianshu, Ma Xiangchi, Zhao Dongxu, Liu Yueyang, Zheng Xueke, Zhao Xudo |
- Page last reviewed:Feb 1, 2023
- Page last updated:May 22, 2023
- Content source: